Role of TLR4 rs4986790A＞G and rs4986791C＞T Polymorphisms in the Risk of Inflammatory Bowel Disease

Torre, D., Tambini, R., Aristodemo, S., Gavazzeni, G., Goglio, A., Cantamessa, C., Pugliese, A., & Biondi, G. (2000). Anti-inflammatory response of IL-4, IL-10 and TGF-β in patients with systemic inflammatory response syndrome. Mediators of Inflammation, 2000(), 193-195. https://doi.org/10.1080/09629350020002912
Huang, J. B., Mei, J., Jiang, L. Y., Jiang, Z. L., Liu, H., Zhang, J. W., & Ding, F. B. (2015). MiR-196a2 rs11614913 T＞C Polymorphism is Associated with an Increased Risk of Tetralogy of Fallot in a Chinese Population. Acta Cardiologica Sinica, 31(1), 18-23. https://doi.org/10.6515/ACS20140310B
Beck, P. L., & Wallace, J. L. (1997). Cytokines in inflammatory bowel disease. Mediators of Inflammation, 1997(), 95-103. https://doi.org/10.1080/09629359791785
Haskey, N., Sánchez, J. N. P., Jones, J. L., & Fowler, S. A. (2018). Development of a screening tool to detect nutrition risk in patients with inflammatory bowel disease. Asia Pacific Journal of Clinical Nutrition, 27(4), 756-762. https://doi.org/10.6133/apjcn.112017.01
Wong, K. Y. (2010). Study of the serologic markers in Chinese patients with inflammatory bowel disease [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200017512